60-day Federal Register Notice

34592

Federal Register / Vol. 83, No. 140 / Friday, July 20, 2018 / Notices

Centers for Disease Control and
Prevention
[60Day–18–18AJJ; Docket No. CDC–2018–
0056]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Knowledge, Attitudes, and
Practices of US Large Animal
Veterinarians Concerning Common
Veterinary Infection Control Measures
When Working with Animal Obstetric
Cases. The goals of this survey are to
better describe veterinarians’ current
knowledge of zoonotic infectious
diseases that cause abortion in large
animals, determine common veterinary
infection control practices when
working up obstetric cases, and identify
common barriers to personal protective
equipment use.
DATES: CDC must receive written
comments on or before September 18,
2018.
SUMMARY:

You may submit comments,
identified by Docket No. CDC–2018–
0056 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.

daltland on DSKBBV9HB2PROD with NOTICES

ADDRESSES:

Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.

VerDate Sep<11>2014

18:06 Jul 19, 2018

Jkt 244001

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
FOR FURTHER INFORMATION CONTACT:

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Proposed Project
Knowledge, Attitudes, and Practices
of U.S. Large Animal Veterinarians
Concerning Common Veterinary
Infection Control Measures When
Working with Animal Obstetric Cases—
New ICR—National Center for Emerging
and Zoonotic Infectious Diseases,
Centers for Disease Control and
Prevention (CDC).

PO 00000

Frm 00057

Fmt 4703

Sfmt 4703

Background and Brief Description
Veterinarians are particularly at risk
of contracting zoonotic infectious
diseases due to their close proximity to
animals, especially during times of
injury or illness. Some veterinarians
may be unaware of recommended
personal protection measures or opt not
to participate in measures that would
decrease their risk of contracting a
zoonotic disease (Wright et al. 2008). In
1977, a survey conducted of 1182
veterinarians showed that
approximately 43% of the respondents
had contracted an infectious zoonotic
disease (Schnurrenberger & Martin
1977). Today, this elevated zoonotic
disease risk persists; the seroprevalence
of Q fever in U.S. veterinarians is 22%
(Whitney, Massung, et al. 2009) and the
seroprevalance of leptospirosis is 2.5%
(Whitney, Ailes, et al. 2009). Within the
veterinary profession, large animal
practitioners might have an increased
risk of occupational exposure to
infectious zoonotic diseases for many
reasons, including decreased biosecurity
measures available in the field and the
limited space available on a mobile
practice for PPE.
The goals of this study are to establish
veterinarians’ knowledge of zoonotic
infectious disease, identify
veterinarians’ attitudes towards
zoonotic infectious disease and personal
risk, and determine practices to
decrease personal risk of infection. By
identifying knowledge gaps in personal
protective equipment (PPE) use,
transmission risk factors, and disease
identification/diagnosis, we aim to
determine the best methods for
education of veterinarians on relevant
abortion-associated zoonotic infectious
diseases.
The purpose of this study is to better
describe veterinarians’ current
knowledge of zoonotic diseases that
cause abortion in large animals,
determine common veterinary infection
control practices when working up
obstetric cases, and identify common
barriers to PPE use. In order to develop
effective messaging strategies, a deeper
understanding of the attitudes and
barriers to PPE use is needed. The
information collected will be used to
improve and enhance zoonotic disease
education and PPE guidance targeted to
veterinarians. The estimated annual
burden hours are 125. There is no cost
to respondents other than their time.

E:\FR\FM\20JYN1.SGM

20JYN1

34593

Federal Register / Vol. 83, No. 140 / Friday, July 20, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

Veterinarian .......................................

...........................................................

500

1

15/60

125

Total ...........................................

...........................................................

........................

........................

........................

125

Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–15528 Filed 7–19–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10675]

Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:

The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
September 18, 2018.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
SUMMARY:

daltland on DSKBBV9HB2PROD with NOTICES

Number of
respondents

Type of respondents

VerDate Sep<11>2014

18:06 Jul 19, 2018

Jkt 244001

recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to http://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork
ReductionActof1995/PRA-Listing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
[email protected].
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10675 Evaluation of the CMS
Quality Improvement Organizations:
Medication Safety and Adverse Drug
Event Prevention
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is

PO 00000

Frm 00058

Fmt 4703

Sfmt 4703

defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: New Collection of Information
Request; Title of Information Collection:
Evaluation of the CMS Quality
Improvement Organizations: Medication
Safety and Adverse Drug Event
Prevention; Use: The purpose of this
Information Collection Request (ICR) is
to collect data to inform the program
evaluation of the Centers for Medicare &
Medicaid Services (CMS) Quality
Improvement Organizations (QIO)
current contract known as the 11th
Scope of Work (SOW). The current ICR
focuses on evaluating one component of
the quality improvement activities of
the Quality Innovation Network Quality
Improvement Organizations (QIN–QIOs)
and is part of a larger evaluation of the
overall impact of the QIO program. This
ICR aims to assess the QIN–QIO Task
which focuses on Medication Safety and
Adverse Drug Event Prevention. For this
evaluation, we are using a mixedmethods design to compare quality
improvement activities of pharmacists,
physicians, and nursing home
administrators or directors of nursing at
nursing homes participating in the QIN–
QIO program (participating) with those
not participating in the QIN–QIO
program (non-participating).
As mandated by Sections 1152–1154
of the Social Security Act, CMS directs
the QIO program, which is one of the
largest federal programs dedicated to
improving health quality for Medicare
beneficiaries. QIOs are groups of health
quality experts, clinicians, and

E:\FR\FM\20JYN1.SGM

20JYN1